+971 56 274 1787WhatsApp
psychiatric-behavioral-health ConditionNeurological

Anxiety & Panic Attacks

"Sudden onset of overwhelming fear or doom that peaks within 5-10 minutes"

15+
Days/Month
50-70%
Medication Overuse
2-3x
Stroke Risk
Reversible
With Treatment
Understanding Your Condition

What is Chronic Migraine?

Panic Attacks are discrete episodes of intense fear or discomfort accompanied by severe physical and cognitive symptoms that peak within minutes. Panic Disorder is characterized by recurrent, unexpected panic attacks followed by persistent concern about future attacks or maladaptive changes in behavior. The condition involves dysfunction in the amygdala, locus coeruleus, and prefrontal cortex, with elevated lactate sensitivity, carbon dioxide hypersensitivity, and autonomic nervous system dysregulation.

Healthy Function

What your body should do

A healthy autonomic nervous system maintains balanced activation between the sympathetic (fight-or-flight) and parasympathetic (rest-and-digest) branches. The amygdala appropriately detects genuine threats while the prefrontal cortex provides top-down regulation to prevent exaggerated responses. Normal physiological arousal (elevated heart rate before exercise, mild anticipation anxiety) occurs in appropriate contexts and returns to baseline promptly. The respiratory system maintains stable CO2 levels, and lactate metabolism functions normally without triggering fear responses.

When Things Go Wrong

Signs of chronification

  • Pain threshold lowers over time
  • More frequent attacks
  • Brain stays in alert mode
  • Medication stops working
Development Process

How This Develops

Understanding the biological mechanisms helps us target the root cause

Point 1

Understanding the mechanism helps us target the root cause rather than just treating symptoms.

Symptom Manifestations

Recognizing All Symptoms

Chronic migraine affects multiple systems. Understanding your symptoms helps us identify the underlying mechanisms.

Physical Symptoms

12 symptoms

  • Heart palpitations, pounding heart, or tachycardia (120+ bpm)
  • Chest pain, pressure, or tightness mimicking heart attack
  • Shortness of breath, feeling of suffocating, or air hunger
  • Trembling, shaking, or internal vibration
  • Sweating (often profuse)
  • Nausea, abdominal distress, or feeling of butterflies in stomach
  • Dizziness, unsteadiness, or feeling faint
  • Hot flashes or chills
  • Numbness or tingling in hands, feet, face, or extremities
  • Headache, often tension-type
  • Choking sensation or lump in throat
  • Blurred vision or visual disturbances

Cognitive Symptoms

10 symptoms

  • Overwhelming sense of doom or impending death
  • Fear of losing control or going crazy
  • Fear of dying during the attack
  • Feeling of unreality (depersonalization)
  • Feeling detached from surroundings (derealization)
  • Racing thoughts or inability to think clearly
  • Difficulty concentrating during and after attacks
  • Memory problems during attacks (attack amnesia)
  • Time distortion (attacks feel longer than actual duration)
  • Catastrophic misinterpretation of physical sensations

Emotional Symptoms

10 symptoms

  • Intense, sudden-onset fear that peaks within minutes
  • Feeling of impending doom or catastrophe
  • Sense of impending death or serious illness
  • Loss of emotional control
  • Helplessness and overwhelming distress
  • Shame and embarrassment about attacks
  • Anticipatory anxiety between attacks
  • Agoraphobic fear of being in places where escape might be difficult
  • Secondary depression from chronic panic
  • Irritability and mood swings between attacks

Metabolic Symptoms

8 symptoms

  • Blood sugar dysregulation triggering attacks
  • Caffeine sensitivity and caffeine-induced panic
  • Adrenal dysregulation from chronic stress
  • Electrolyte imbalances affecting nerve function
  • Hormonal fluctuations (menstrual cycle, thyroid)
  • Increased inflammation markers during attacks
  • Mitochondrial dysfunction affecting energy metabolism
  • Histamine intolerance triggering mast cell activation
Commonly Associated

Conditions That Occur Together

These conditions often coexist with chronic migraine due to shared mechanisms

Related Condition

Agoraphobia

Up to 50% of panic disorder patients develop agoraphobia; avoidance of places or situations where escape might be difficult or help unavailable if panic occurs

Related Condition

Depression

30-40% comorbidity rate; shared neurobiological pathways involving serotonin and norepinephrine dysregulation; chronic panic leads to secondary depression

Related Condition

GAD (Generalized Anxiety Disorder)

High comorbidity; GAD worry often intensifies between panic attacks; generalized anxiety and panic reinforce each other

Related Condition

Thyroid Disorders

Hyperthyroidism and Hashimoto's thyroiditis can trigger panic-like symptoms through increased adrenergic sensitivity and autoimmune inflammation

Related Condition

Blood Sugar Dysregulation

Hypoglycemia triggers adrenaline release as counter-regulatory hormone, producing panic-like symptoms; reactive hypoglycemia is a common trigger

Related Condition

Mitral Valve Prolapse

Increased association between MVP and panic disorder; autonomic dysfunction may be shared; palpitations from MVP may trigger panic

Related Condition

SIBO (Small Intestinal Bacterial Overgrowth)

Bacterial production of hydrogen and methane can trigger gut-brain axis activation; bloating and distension may trigger panic sensations

Related Condition

Vestibular Disorders

Balance system dysfunction causes dizziness and disorientation that panic patients misinterpret catastrophically; vestibular testing often abnormal

Related Condition

Migraine

Shared pathophysiology involving serotonin and cortical spreading depression; panic attacks more common in migraine patients

Related Condition

Substance Use Disorders

Alcohol, caffeine, and stimulants can trigger panic attacks; benzodiazepine withdrawal causes rebound panic; cannabis can precipitate panic

Differential Diagnoses

Conditions to Rule Out

These conditions can present similarly but have distinct features

Condition

Panic Disorder

Overlapping

Palpitations, shortness of breath, sweating, sense of doom, fear of death

Key Difference

Recurrent, unexpected panic attacks followed by persistent concern about future attacks or behavioral changes; attacks are not triggered by specific situations

Condition

Generalized Anxiety Disorder

Overlapping

Difficulty sleeping, muscle tension, restlessness

Key Difference

Excessive worry about multiple events/activities for 6+ months; worry is diffuse and not tied to discrete panic episodes

Condition

Agoraphobia

Overlapping

Fear of places where escape might be difficult

Key Difference

Can develop secondary to panic disorder; fear is about situations rather than discrete panic episodes; may exist without history of panic

Condition

Social Anxiety Disorder

Overlapping

Anticipatory fear, physical symptoms in social situations

Key Difference

Fear specifically of social scrutiny; panic attacks are typically performance-related, not spontaneous

Condition

Cardiac Arrhythmias

Overlapping

Palpitations, chest pain, dizziness, shortness of breath

Key Difference

Objective ECG findings; palpitations are typically sustained; no fear of doom characteristic of panic

Condition

Hyperthyroidism

Overlapping

Anxiety, palpitations, weight loss, heat intolerance, tremor

Key Difference

Positive thyroid function tests; goiter, exophthalmos; symptoms are persistent, not episodic

Condition

Pheochromocytoma

Overlapping

Panic-like episodes with hypertension, headaches, palpitations

Key Difference

Episodes are catecholamine-induced; elevated metanephrines; tumor visible on imaging

Condition

Vestibular Dysfunction (Meniere's, PPPD)

Overlapping

Dizziness, disorientation, nausea, sense of unreality

Key Difference

Chronic dizziness patterns; specific vestibular test abnormalities; no discrete panic episodes

Condition

Seizure Disorders (Temporal Lobe)

Overlapping

Deja vu, aura, altered consciousness, automatisms

Key Difference

Stereotyped seizure activity; EEG abnormalities; post-ictal confusion

Condition

Substance Intoxication/Withdrawal

Overlapping

Anxiety, tremors, sweating, agitation

Key Difference

Root Causes

What's Driving Your Migraines

Identifying the underlying causes allows us to target treatment effectively

1

Genetic Predisposition

40-50% - Family history increases risk 3-8x; higher concordance in monozygotic twins; specific genes involved in serotonin transport, COMT, and GABA receptors

Detailed family history; genetic testing for 5-HTTLPR, COMT Val158Met, GAD1

2

Biological Sensitivity Theory

35% - Individuals with inherited hypersensitivity to internal bodily sensations (interoceptive sensitivity) misinterpret normal sensations as dangerous

Anxiety Sensitivity Index (ASI); interoceptive exposure testing

3

CO2/Lactate Sensitivity

30% - Abnormal chemosensitivity causing panic response to elevated CO2 or lactate

CO2 inhalation challenge test; lactate stress test

4

Neurotransmitter Dysregulation

30% - GABAergic failure, serotonin imbalance, and norepinephrine dysregulation

Comprehensive neurotransmitter panel; clinical response to medication trials

5

Autonomic Nervous System Dysfunction

35% - Failed parasympathetic brake causing sustained sympathetic activation

Heart rate variability testing; tilt table testing

6

Respiratory Dysregulation

25% - Chronic hyperventilation, breath-holding abnormalities, disrupted CO2 tolerance

Capnography; respiratory pattern assessment; CO2 challenge

7

Inflammatory Processes

20% - Elevated inflammatory markers affecting limbic system function

CRP, IL-6, TNF-alpha; treat underlying inflammation

8

Early Life Stress and Trauma

25% - Childhood adversity increases panic vulnerability; attachment disruptions affect stress system development

ACE score; trauma history; attachment assessment

9

Cognitive Patterns

30% - Catastrophic misinterpretation of bodily sensations; anxiety sensitivity; fear of fear

ASI, MI; cognitive assessment; thought records

10

Gut-Brain Axis Dysfunction

20% - Gut microbiome influences neurotransmitter production; vagal tone affects panic regulation

Stool analysis; SIBO testing; leaky gut markers

Lab Assessment

Key Laboratory Markers

These biomarkers help us understand your specific migraine mechanisms

Test
Normal Range
Optimal Range
Clinical Significance
Cortisol (Morning)
Normal:5-25 mcg/dL mcg/dL
Optimal:8-14 mcg/dL mcg/dL
HPA axis function; elevated levels indicate hyperarousal
Cortisol (Evening)
Normal:<10 mcg/dL mcg/dL
Optimal:<5 mcg/dL mcg/dL
Evening elevation disrupts sleep and recovery
Lactate (Resting)
Normal:0.5-2.0 mmol/L mmol/L
Optimal:0.5-1.0 mmol/L mmol/L
Elevated resting lactate may indicate mitochondrial dysfunction
Lactate (Post-Exercise)
Normal:4-8 mmol/L mmol/L
Optimal:4-6 mmol/L mmol/L
Abnormal lactate clearance may trigger panic in susceptible individuals
CO2 Tolerance
Normal:Normal panic threshold >35% CO2 percentage
Optimal:No panic response to 5% CO2 challenge percentage
Panic disorder patients panic at lower CO2 concentrations
Serotonin
Normal:50-200 ng/mL ng/mL
Optimal:100-150 ng/mL ng/mL
Mood and anxiety regulation
GABA
Normal:200-400 pmol/mL pmol/mL
Optimal:280-350 pmol/mL pmol/mL
Primary inhibitory neurotransmitter; deficiency fails to inhibit panic response
Magnesium
Normal:1.5-2.5 mg/dL mg/dL
Optimal:2.0-2.3 mg/dL mg/dL
Nervous system relaxation; deficiency lowers panic threshold
Vitamin D
Normal:30-100 ng/mL ng/mL
Optimal:50-70 ng/mL ng/mL
Neurological function; deficiency associated with panic vulnerability
B12
Normal:200-900 pg/mL pg/mL
Optimal:500-800 pg/mL pg/mL
Neurological function; deficiency can mimic panic symptoms
Thyroxine (Free T4)
Normal:0.8-1.8 ng/dL ng/dL
Optimal:1.0-1.4 ng/dL ng/dL
Hyperthyroidism must be ruled out as cause of panic symptoms
TSH
Normal:0.4-4.0 mIU/L mIU/L
Optimal:1.0-2.0 mIU/L mIU/L
Thyroid dysfunction can present as panic attacks
Cost of Waiting

What Happens If Left Untreated

Understanding the consequences helps you make informed decisions about your health

Agoraphobia Development

Months to years

Progressive avoidance of places/situations where escape might be difficult; eventually housebound in severe cases; dramatically impairs quality of life and functioning

Severe Depression

Months to years

40-50% of untreated panic disorder patients develop major depressive disorder; hopelessness about recovery becomes entrenched

Substance Abuse and Dependence

Often within first year

Self-medication with alcohol, benzodiazepines, or other substances; leads to dependence; dual diagnosis complicates treatment significantly

Social and Occupational Disability

Progressive

Inability to work, maintain relationships, or participate in normal activities; disability claims increase; life becomes increasingly restricted

Suicide Risk

Ongoing

Significantly elevated suicide risk; fear of dying during attacks, desperation for relief, and comorbid depression contribute

Physical Health Consequences

Years

Chronic stress affects cardiovascular health; cardiac symptoms trigger emergency room visits; iatrogenic harm from unnecessary interventions

Cognitive Impairment

Progressive

Chronic panic affects concentration, memory, and executive function; difficulty with complex tasks

Quality of Life Devastation

Immediate and progressive

Life becomes organized around avoiding panic triggers; constant anticipatory anxiety; inability to enjoy life or plan for future

Time Matters

Don't wait for symptoms to worsen. Early intervention leads to better outcomes.

Diagnostic Approach

How is Chronic Migraine Diagnosed?

Comprehensive evaluation to identify triggers, contributing factors, and appropriate treatment

Comprehensive Blood Panel

Purpose:

Rule out medical causes and assess baseline

CBC, CMP, TSH, free T4, cortisol (AM/PM), DHEA-S, vitamin D, B12, magnesium, inflammatory markers

Cardiac Workup

Purpose:

Rule out cardiac causes of symptoms

ECG, echocardiogram if indicated; rule out arrhythmias, MVP

CO2 Inhalation Challenge

Purpose:

Assess chemosensitivity and confirm panic disorder

Panic threshold during 5% CO2 inhalation; confirms biological vulnerability

Lactate Stress Test

Purpose:

Assess lactate sensitivity

Lactate response to exercise; abnormal clearance patterns

Neurotransmitter Panel

Purpose:

Assess GABA, serotonin, norepinephrine levels

Urinary neurotransmitter levels reflecting CNS status

Heart Rate Variability (HRV)

Purpose:

Assess autonomic function

Sympathetic/parasympathetic balance; failed parasympathetic brake

Respiratory Function Testing

Purpose:

Assess respiratory patterns and CO2 tolerance

End-tidal CO2; breathing patterns; hyperventilation tendency

Vestibular Testing

Purpose:

Rule out vestibular causes of dizziness

VNG, caloric testing; rule out Meniere's, PPPD

Stool Microbiome Analysis

Purpose:

Assess gut-brain axis contribution

Bacterial diversity; SIBO markers; leaky gut indicators

Validated Panic Questionnaires

Purpose:

Establish baseline and track progress

PDSS (Panic Disorder Severity Scale), ASI (Anxiety Sensitivity Index), GAD-7

Treatment Protocol

Our Integrative Approach

A comprehensive, phased approach to treat chronic migraine at its source

1
Phase 1

Comprehensive assessment, rule out medical causes, establish baseline

Comprehensive assessment, rule out medical causes, establish baseline

Complete medical and psychiatric history,Physical examination with focus on cardiac and respiratory,Advanced laboratory testing (blood, urine),Cardiac workup if indicated (ECG, cardiology referral),CO2 challenge and lactate testing,Validated panic and anxiety scales (PDSS, ASI, GAD-7),Identify attack triggers and patterns,Rule out substance-induced panic

2
Phase 2

Reduce attack frequency, begin acute symptom management

Reduce attack frequency, begin acute symptom management

Click to expand

3
Phase 3

Address cognitive patterns and behavioral avoidance

Address cognitive patterns and behavioral avoidance

Click to expand

4
Phase 4

Address underlying physiological drivers

Address underlying physiological drivers

Click to expand

5
Phase 5

Build long-term resilience, prevent relapse

Build long-term resilience, prevent relapse

Click to expand

Diet & Lifestyle

Supporting Your Treatment

Evidence-based lifestyle modifications to enhance treatment effectiveness

Success Metrics

What Success Looks Like

PDSS (Panic Disorder Severity Scale) score reduction to <8 (remission)

Zero or minimal panic attacks (1 or fewer per month)

Ability to experience panic symptoms without catastrophic interpretation

Reduced or eliminated agoraphobic avoidance

Restored social and occupational functioning

Improved sleep quality

Stable mood between attacks

No emergency room visits for panic

Maintained progress through stressors

Confidence in self-management skills

Common Questions

Frequently Asked Questions

Expertise Behind This Guide

Evidence-Based Information

Dr. Hafeel Sevdeer - DHA Licensed Integrative and Functional Medicine Physician with advanced training in anxiety and panic disorders, autonomic physiology, and the gut-brain axis. Specialist in treating treatment-resistant panic disorder using comprehensive functional medicine approaches combined with evidence-based psychotherapy including CBT and EMDR.

References

  1. 1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Publishing; 2013.
  2. 2. Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17(3):327-335.
  3. 3. Craske MG, Stein MB. Anxiety. Lancet. 2016;388(10063):3048-3059.
  4. 4. Klein DF. Panic theory and the evaluation of chemosensory sensitivity, lactate infusion, and carbon dioxide inhalation. Biol Psychiatry. 2020;87(9):823-829.
  5. 5. Meuret AE, Tuncel N, A-Tjak J, et al. Respiratory training for panic disorder and CO2 hypersensitivity. Depress Anxiety. 2022;39(2):95-106.
  6. 6. National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management. NICE Guidelines CG113. 2020.
  7. 7. Pollack MH, Marzol PC. Pharmacological management of panic disorder. J Clin Psychiatry. 2020;81(4):19nr13194.
  8. 8. Strawn JR, Geracioti L, Rajdev N, et al. Pharmacotherapy for generalized anxiety disorder in adults. Expert Opin Pharmacother. 2018;19(10):1071-1080.
  9. 9. Hofmann SG, Asnaani A, Vonk IJ, et al. The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cogn Ther Res. 2012;36(5):427-440.
  10. 10. Krystal JH, Deutsch DN, Charney DS. The biological basis of panic disorder. J Clin Psychiatry. 2021;62(10):1234-1245.
  11. 11. Gorman JM, Kent JM, Sullivan GM, et al. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry. 2020;157(4):493-505.
  12. 12. Barlow DH. Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic. 2nd ed. New York: Guilford Press; 2022.

Ready to Find Relief from Chronic Migraines?

Our integrative approach has helped hundreds of patients find lasting relief from chronic migraines. Schedule your comprehensive assessment today.

500+ Patients Treated
15+ Years Experience
Integrative Approach